Aarti Drugs Limited has informed the Exchange about Copy of Newspaper Publication
AARTIDRUGS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aarti Drugs Limited has submitted to BSE and NSE copies of a newspaper notice published on June 14, 2025 informing equity shareholders about the proposed transfer of their shares to the Investor Education and Protection Fund (IEPF) Account. The notice was published in Financial Express (English) and Mumbai Pratahkal (Marathi), as required under Section 124(6) of the Companies Act, 2013 read with the IEPF Authority Rules, 2016. Under these rules, shares of shareholders who have not claimed dividends for seven consecutive years are transferred to the IEPF. The filing is a routine regulatory disclosure under SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015.
This is a routine compliance filing with no direct impact on stock price. Shareholders of Aarti Drugs who have not claimed dividends for 7 or more consecutive years should act promptly to claim their shares before the transfer date, otherwise their shares will be moved to the IEPF and can only be reclaimed by following a refund process with the IEPF Authority.